Disposition of 1200000 shares by Topper James N of Alpine Immune at 0.001 subject to Rule 16b-3

ALPNDelisted Stock  USD 12.37  0.23  1.83%   
About 62% of Alpine Immune's investor base is looking to short. The analysis of current outlook of investing in Alpine Immune Sciences suggests that many traders are alarmed regarding Alpine Immune's prospects. Alpine Immune's investing sentiment overview a quick insight into current market opportunities from investing in Alpine Immune Sciences. Many technical investors use Alpine Immune Sciences stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
Filed transaction by Alpine Immune Sciences Director. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Read at macroaxis.com
Disposition of 1200000 warrant (right to buy) at 0.001 of Alpine Immune by Topper James N on 25th of April 2024. This event was filed by Alpine Immune Sciences with SEC on 2024-04-25. Statement of changes in beneficial ownership - SEC Form 4

Alpine Immune Fundamental Analysis

We analyze Alpine Immune's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Alpine Immune using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Alpine Immune based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Book Value Per Share

Book Value Per Share Comparative Analysis

Alpine Immune is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.

Alpine Immune Sciences Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Alpine Immune stock to make a market-neutral strategy. Peer analysis of Alpine Immune could also be used in its relative valuation, which is a method of valuing Alpine Immune by comparing valuation metrics with similar companies.

Peers

Alpine Immune Related Equities

ANEBAnebulo Pharmaceuticals   7.64   
0%
78.0%
ADAGAdagene   6.39   
0%
65.0%
TERNTerns Pharmaceuticals   3.41   
0%
34.0%
ACRVAcrivon Therapeutics,   0.13   
0%
1.0%
DAWNDay One   1.81   
18.0%
0%
IGMSIGM Biosciences   2.22   
22.0%
0%
BCYCBicycle Therapeutics   2.80   
28.0%
0%
ABOSAcumen Pharmaceuticals   2.98   
30.0%
0%
TNYATenaya Therapeutics   3.35   
34.0%
0%
GLUEMonte Rosa   3.52   
36.0%
0%
AMLXAmylyx Pharmaceuticals   3.60   
36.0%
0%
MLYSMineralys Therapeutics,   4.60   
47.0%
0%
STOKStoke Therapeutics   5.30   
54.0%
0%
MLTXMoonLake Immunotherapeuti   7.52   
77.0%
0%
ANABAnaptysBio   9.76   
100.0%
0%
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Consideration for investing in Alpine Stock

If you are still planning to invest in Alpine Immune Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Alpine Immune's history and understand the potential risks before investing.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios